P36 Outcomes of general practitioner prescription of direct acting antiviral therapy utilising a remote consultation referral pathway in Western Victoria by A.J. Wade, A. McCormack, C. Roder, K. McDonald, M. Wardrop, E. Athan, M.E. Hellard

Connect to this object online.

O17 Eliminate Hepatitis C Partnership: clinical site scoping by E. Wong, A. Pedrana, B.L. Draper, J. Gold, J. Richmond, M. Stoove, J.S. Doyle, A.J. Thompson, M.E. Hellard

Connect to this object online.

O20 Opportunities and challenges experienced when treating HCV in people who inject drugs (PWID) through a nurse-led outreach model by K. Allardice, S. Von Bibra, J.S. Doyle, P.M. Dietze, P. Desmond, M. Stoove, E. McBryde, P. Higgs, A.J. Thompson, M.E. Hellard

Connect to this object online.

O5 Hepatitis C elimination in HIV/HCV co-infection through HCV treatment in primary care is feasible and highly effective by J.S. Doyle, A.L. Bowring, J. Cutts, J. Roney, D.M. Iser, J. Sasadeusz, M. O'Reilly, C. Fairley, E. Gane, J. Hoy, G.V. Matthews, N. Medland, R. Moore, M. Prins, M. Stoové, B.K. Tee, M.E. Hellard

Connect to this object online.

O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study by J. Grebely, O. Dalgard, B. Conway, E. Cunningham, P. Bruggmann, B. Hajarizadeh, J. Amin, P. Marks, S. Quiene, T.L. Applegate, T. Swan, J. Byrne, M. Lacalamita, A. Dunlop, J. Bruneau, M.E. Hellard, G.V. Matthews, J. Powis, D. Shaw, M.C. Thurnheer, M. Weltman, I. Kronborg, C. Cooper, J.J. Feld, C. Fraser, A. Litwin, J. Dillon, P. Read, E. Gane, G.J. Dore

Connect to this object online.